معرفی
Tony Succar is an Assistant Professor (Teaching Track) in the Department of Regulatory and Quality Sciences at the University of Southern California. He serves as the Director of the Master of Science in Clinical Trial Management program and as the Associate Director for the Regulatory Knowledge and Support (RKS) Core at the Southern California Clinical and Translational Science Institute (SCCTSI). Additionally, he is an invited instructor for the Alpha Clinic Clinical Trial Investigator Training Program at the University of California, Irvine.
His educational background is extensive:
- PhD from University of Sydney Medical School
- Master of Science in Medicine (Ophthalmic Science) from University of Sydney Medical School
- Graduate Certificate in Educational Studies (Higher Education) from University of Sydney School of Education
- Postdoctoral Fellowship at Keck School of Medicine of USC
Dr. Succar's research focuses on optimizing clinical trial designs for pharmaceuticals, stem cell and gene therapies, medical devices, and combination products. He is particularly interested in applying regulatory and translational research to develop innovative educational tools, such as the Virtual Ophthalmology Clinic, and in vision rehabilitation for central vision loss. His work integrates advanced imaging techniques like optical coherence tomography angiography to study retinal diseases.
His notable scientific awards include:
- Best Oral Presentation in Educational Research at the Annual Nepean Scientific Day
- Higher Education Research and Development Society of Australia (HERDSA) Conference Grant
- Two articles ranked among the top 100 most-cited in Ophthalmic Education
- Best of Journal of Academic Ophthalmology (JAO)
Dr. Succar actively supervises Doctor of Regulatory Science candidates, Doctor of Pharmacy Scholarly Projects, and Directed Research Projects. His grant history includes the University of Sydney Postgraduate Scholarship in Vision and Eye Health Research. He is the inventor of a patented virtual vision rehabilitation program (US10857060B2) for restoring functional 3D vision in individuals with central vision loss.
